CIK 0001678660 · Non-accelerated filer<br>Smaller reporting company
Prelude Therapeutics Inc
Sign in to watch- Ticker
- PRLD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811384762
- Phone
- (302) 467-1280
- Business address
- 175 INNOVATION BOULEVARD, WILMINGTON, DE, 19805
- Former names
- Prelude Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 62 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-18 | Vaddi Krishna CEO | Purchase | +100,000 | $0.93 | $93K | 1,167,275 |
| 2024-10-04 | Huang Jane President, CMO | Option exercise | +9,375 | 66,690 | ||
| 2024-10-04 | Huang Jane President, CMO | Shares withheld for taxes | −3,349 | $2.00 | $7K | 63,341 |
| 2024-10-04 | Huang Jane President, CMO | Option exercise · Restricted Stock Unit | −9,375 | 56,250 | ||
| 2024-07-04 | Huang Jane President, CMO | Option exercise | +9,375 | 60,662 | ||
| 2024-07-04 | Huang Jane President, CMO | Shares withheld for taxes | −3,347 | $3.60 | $12K | 57,315 |
| 2024-07-04 | Huang Jane President, CMO | Option exercise · Restricted Stock Unit | −9,375 | 65,625 | ||
| 2024-06-14 | Sandor Victor Director | Grant or award · Director Stock Option (Right to Buy) | +23,500 | 23,500 | ||
| 2024-06-14 | FRIEDMAN PAUL A Director | Grant or award · Director Stock Option (Right to Buy) | +23,500 | 23,500 | ||
| 2024-06-14 | Dier Mardi Director | Grant or award · Director Stock Option (Right to Buy) | +23,500 | 23,500 | ||
| 2024-06-14 | Bonita David P Director | Grant or award · Director Stock Option (Right to Buy) | +23,500 | 23,500 | ||
| 2024-06-14 | Babler Martin Director | Grant or award · Director Stock Option (Right to Buy) | +23,500 | 23,500 | ||
| 2024-06-14 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +23,500 | 23,500 | ||
| 2024-06-14 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +23,500 | 23,500 | ||
| 2024-05-14 | Lim Bryant David CLO, Interim CFO, Corp Sec. | Grant or award · Employee Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2024-04-04 | Huang Jane President, CMO | Option exercise | +9,375 | 54,634 | ||
| 2024-04-04 | Huang Jane President, CMO | Shares withheld for taxes | −3,347 | $4.74 | $16K | 51,287 |
| 2024-04-04 | Huang Jane President, CMO | Option exercise · Restricted Stock Unit | −9,375 | 75,000 | ||
| 2024-03-01 | Lim Bryant David Chief Legal Officer, Corp Sec. | Grant or award · Employee Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2024-03-01 | Scherle Peggy Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +150,000 | 150,000 |
Page 4 of 8 · 141 trades